Regulators Give Roche Green Light For $4.3B Spark Therapeutics Acquisition

Roche Holding has received approval from the Federal Trade Commission and Britain’s Competition and Markets Authority to acquire Spark Therapeutics, Inc. the companies announced Tuesday.